What is Arcutis Biotherapeutics, Inc.'s Shariah compliance score?

Arcutis Biotherapeutics, Inc. (ARQT) has a Shariah compliance score of 73/100 (Grade: B+, Good) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does Arcutis Biotherapeutics, Inc. pass AAOIFI screening?

Arcutis Biotherapeutics, Inc. (ARQT) passes AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (ARQT: 3.1%), (3) interest-bearing deposits below 30% (ARQT: 6.2%), and (4) prohibited income below 5% (ARQT: 3.9%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for Arcutis Biotherapeutics, Inc. stock?

Arcutis Biotherapeutics, Inc. (ARQT) has a non-permissible income ratio of 3.85%. Muslim investors should purify this percentage of any dividends received and capital gains realized from ARQT shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen Arcutis Biotherapeutics, Inc. for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for Arcutis Biotherapeutics, Inc. (ARQT) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about ARQT's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

ARQT: Is Arcutis Biotherapeutics, Inc. Halal?

Arcutis Biotherapeutics, Inc.

NASDAQHealthcareUS

$20.79

-3.17%

Market Cap: 2.6B

Compliance Status

Halal

Screened on Jul 18, 2026 · AAOIFI Standard 21

B+

Good

73Score

Is Arcutis Biotherapeutics, Inc. (ARQT) halal? Halal. Based on AAOIFI screening, Arcutis Biotherapeutics, Inc. passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 73/100 (Grade: B+).

AvoidBorderlineClean

Business activity

What the company sells is permissible.

Passed

Company debt

Well clear of the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

3.1% of 30.0% limit

What this means for you

You can own ARQT

It passes both the business activity and financial ratio screens under AAOIFI Standard 21.

Purify 3.9% of your income from ARQT

That is about $3.90 of every $100 you earn from it. Donate this share to charity.

Calculate my exact amount

About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Sector: Healthcare · Industry: Biotechnology

Shariah Compliance Status

AAOIFI Standard 21Updated Jul 18, 2026

Compliance History

Halalnow
since Jun 2026
Not Halal
until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Fiscal: Q1 2026Data source: EDGAR

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track ARQT and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Arcutis Biotherapeutics, Inc. (ARQT) halal to invest in?

Based on AAOIFI Standard 21 screening, Arcutis Biotherapeutics, Inc. (ARQT) is rated Halal with a compliance grade of B+ (Good). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).

Why did Arcutis Biotherapeutics, Inc. get a B+ compliance rating?

Arcutis Biotherapeutics, Inc. (ARQT) received a grade of B+ (Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 3.1% (limit 30%); interest-bearing deposits of 6.2% (limit 30%); prohibited income of 3.85% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change Arcutis Biotherapeutics, Inc.'s Shariah verdict?

Arcutis Biotherapeutics, Inc.'s verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is Arcutis Biotherapeutics, Inc. re-screened for Shariah compliance?

Arcutis Biotherapeutics, Inc. (ARQT) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jul 18, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.